Published: Guidance, quality standards and advice

Skip to filtersSkip to results

Skip to results

Keyword or reference number

Keyword or reference number

Last updated date

Last updated date

Type

Guidance programme

HealthTech approach

HealthTech approach

Advice programme

Area of interest

Showing 126 to 150 of 2564

TitleReference numberPublishedLast updated
Mirabegron for treating neurogenic detrusor overactivity in people 3 to 17 years (terminated appraisal)TA1100
HIV testing: increasing uptake among people who may have undiagnosed HIVNG60
Isatuximab in combination for untreated multiple myeloma when a stem cell transplant is unsuitableTA1098
Atopic eczema in under 12s: diagnosis and managementCG57
Digital technologies to deliver pulmonary rehabilitation programmes for adults with COPD: early value assessmentHTG718
Enfortumab vedotin with pembrolizumab for untreated unresectable or metastatic urothelial cancer when platinum-based chemotherapy is suitableTA1097
DMD Care UK's guideline on cardiac care of children with dystrophinopathy and females carrying DMD-gene variations: NICE reviewNR1
Chronic heart failure in adultsQS9
Benralizumab for treating relapsing or refractory eosinophilic granulomatosis with polyangiitisTA1096
Chronic heart failure in adults: diagnosis and managementNG106
Pneumonia: diagnosis and managementQS110
Suspected acute respiratory infection in over 16s: assessment at first presentation and initial managementNG237
Pneumonia: diagnosis and managementNG250
Bipolar disorder: assessment and managementCG185
Tirzepatide for managing overweight and obesityTA1026
Tirzepatide for treating type 2 diabetesTA924
Idebenone for treating visual impairment in Leber's hereditary optic neuropathy in people 12 years and overTA1093
Guselkumab for treating moderately to severely active ulcerative colitisTA1094
Guselkumab for previously treated moderately to severely active Crohn's diseaseTA1095
Compression products for treating venous leg ulcers: late-stage assessmentHTG758
Bed frames for adults in acute medical or surgical hospital wards: late-stage assessmentHTG759
Pembrolizumab with carboplatin and paclitaxel for untreated primary advanced or recurrent endometrial cancerTA1092
Transcatheter heart valves for transcatheter aortic valve implantation to treat aortic stenosis: late-stage assessmentHTG757
Tarlatamab for extensive-stage small-cell lung cancer after 2 or more treatmentsTA1091
Durvalumab with tremelimumab for untreated advanced or unresectable hepatocellular carcinomaTA1090

Results per page

  1. 10
  2. 25
  3. 50
  4. All